Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - iron (iii) hydroxide polymaltose complex -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - iron (iii) hydroxide polymaltose complex -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - iron(iii) hydroxide polymaltose complex; folic acid; ascorbic acid -

Philippines - English - FDA (Food And Drug Administration)

genpharm, inc.; distributor: genpharm, inc. - iron (as ferric hydroxide polymaltose complex) , folic acid - chewable tablet - 100mg/ 500mcg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - iron polymaltose 50 mg/ml (159mg/ml iron hydroxide polymaltose complex =50mg/ml iron) - solution for injection - 100mg/2ml - active: iron polymaltose 50 mg/ml (159mg/ml iron hydroxide polymaltose complex =50mg/ml iron) excipient: hydrochloric acid sodium hydroxide water for injection - for the prevention and treatment of iron deficiency anaemia in the following circumstances: · when oral therapy is contraindicated · when enteric absorption of iron is defective · when patient non-compliance or persistent gastrointestinal intolerance makes oral therapy impractical · treating iron deficiency anaemia of prematurity and that occurring in geriatric patients · treating iron deficiency states discovered in the third trimester of pregnancy · anaemia resulting from excessive blood loss · where contact between the doctor and patient occurs at irregular intervals

Israel - English - Ministry of Health

uni-pharma kleon tsetis pharmaceutical laboratories ltd. - ferric hydroxide polymaltose complex as - drops - ferric hydroxide polymaltose complex as 50 mg/ml - ferric hydroxide - ferric hydroxide - prevention and treatment of iron deficiency anaemia.

Kenya - English - Pharmacy and Poisons Board

emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex & folic… - capsule - iron (iii) hydroxide polymaltose complex… - antianemic preparations - iron preparations: iron

Australia - English - Department of Health (Therapeutic Goods Administration)

sigma company limited - iron polymaltose, quantity: 318 mg (equivalent: iron, qty 100 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 8 april 2002: for the treatment of iron deficiency anaemia in the following circumstances: * when oral therapy is contraindicated. * when enteric absorption of iron is defective. * when patient non-compliance or persistent gastrointestinal intolerance makes oral therapy impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ferric carboxymaltose, quantity: 1800 mg (equivalent: iron, qty 500 mg) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ferric carboxymaltose, quantity: 360 mg (equivalent: iron, qty 100 mg) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.